Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment

Archive ouverte

Dufournet, Boris | Nguyen, Karine | Charles, Perrine | Grabli, David | Jacquette, Aurelia | Borg, Michel | Danaila, Teodor | Mutez, Eugénie | Drapier, Sophie | Colin, Olivier | Eusebio, Alexandre | Philip, Nicole | Azulay, Jean Philippe

Edité par CCSD ; Elsevier Masson -

International audience. Background. - While it is known that 22q11.2 microdeletions (22q11.2-del) increase the risk of Parkinson's disease (PD), the characteristics of PD associated with 22q11.2-del have not been specifically explored.Objective. - This report aimed to assess the clinical characteristics and treatment responses of PD patients with 22q11.2-del, and to describe any features that might lead neurologists to investigate the comorbidity.Methods. - Nine PD patients (eight men, one woman) with 22q11.2-del were followed at seven centers of the French PD Expert Network (Ns-Park). Results. - PD diagnosis was made before 22q11.2-del diagnosis in seven cases; their main characteristics were early onset (32-48 years) and good initial levodopa sensitivity, but with a course characterized by severe and early-onset levodopa-induced motor complications and psychiatric manifestations. Three patients received deep brain stimulation (DBS) that was effective.Conclusion. - Searching for 22q11.2-del in PD patients presenting with suggestive features is relevant as the clinical presentation is similar to idiopathic PD, but with other associated characteristics, including a severe evolution. Results with DBS are similar to those reported for idiopathic PD.

Suggestions

Du même auteur

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2

Archive ouverte | Boot, Erik | CCSD

International audience

Amantadine use in the French prospective NS-Park cohort

Archive ouverte | Fabbri, Margherita | CCSD

International audience. Objective: To assess amantadine use and associated factors in the patients with Parkinson's disease (PD).Background: Immediate-release amantadine is approved for the treatment of PD and is la...

Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson’s disease

Archive ouverte | Béreau, Matthieu | CCSD

International audience. Postoperative apathy is a frequent symptom in Parkinson’s disease patients who have undergone bilateral deep brain stimulation of the subthalamic nucleus. Two main hypotheses for postoperativ...

Chargement des enrichissements...